There are 4 papers on lysophosphatidylcholine 18:2 in aging research: 4 observational studies in people.
4 papers study it1 finding
See all 4 papers on lysophosphatidylcholine 18:2
“lower lysophosphatidylcholine 18:2, a lipid associated with mitochondrial function”
- Humans4
Associations
1Slow gait
downin humans1
1 study
Slow gait
downin humans1
Slow gait is associated with lysophosphatidylcholine 18:2 in humans (presymptomatic stage before cognitive impairment or dementia).
“lower lysophosphatidylcholine 18:2, a lipid associated with mitochondrial function”
Humanspresymptomatic stage before cognitive impairment or dementia
Presymptomatic Profiles of Cognitive Impairment with Prior Mobility Impairment
Journal of the American Medical Directors Association
Latest
Journal of the American Medical Directors Association
Presymptomatic Profiles of Cognitive Impairment with Prior Mobility Impairment
Cohort study in peopleCognitive impairment
BMC Geriatrics
Specific lysophosphatidylcholine and acylcarnitine related to sarcopenia and its components in older men
Cross-sectional study of 246 peopleAcylcarnitines
Frontiers in Medicine
Specific Metabolites Involved in Antioxidation and Mitochondrial Function Are Correlated With Frailty in Elderly Men
Cross-sectional study of 246 peopleBiomarkers
The Journals of Gerontology, Series A
Targeted Metabolomics Shows Low Plasma Lysophosphatidylcholine 18:2 Predicts Greater Decline of Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging
Cohort study of 504 peopleGait speed